A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression.


Journal

Case reports in oncological medicine
ISSN: 2090-6706
Titre abrégé: Case Rep Oncol Med
Pays: United States
ID NLM: 101581035

Informations de publication

Date de publication:
2019
Historique:
received: 06 03 2019
accepted: 23 06 2019
entrez: 30 7 2019
pubmed: 30 7 2019
medline: 30 7 2019
Statut: epublish

Résumé

Squamous cell carcinoma (SCC) is the most common subtype of vulvar cancer. Locoregional surgery is often curative when the tumor is diagnosed at an early stage. However, the disease can unexpectedly evolve with a dismal prognosis even after an early diagnosis. We report a case of a woman who experienced a rapid, chemorefractory tumor progression after surgery for stage IB vulvar SCC.

Identifiants

pubmed: 31355032
doi: 10.1155/2019/1018492
pmc: PMC6636578
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1018492

Références

Gynecol Oncol. 2003 Apr;89(1):185-8
pubmed: 12694676
Int J Gynecol Cancer. 2004 Mar-Apr;14(2):384-7
pubmed: 15086744
Gynecol Oncol. 2006 Oct;103(1):293-9
pubmed: 16631238
Gynecol Oncol. 2010 Apr;117(1):82-7
pubmed: 20092880
J Am Acad Dermatol. 2010 Dec;63(6):1088-91
pubmed: 20226566
J Skin Cancer. 2011;2011:951250
pubmed: 21188235
Ann Oncol. 2016 Sep;27(9):1696-705
pubmed: 27329249
Gynecol Oncol. 2016 Sep;142(3):427-34
pubmed: 27401841
Int J Gynecol Cancer. 2017 May;27(4):832-837
pubmed: 28441255
J Obstet Gynaecol. 2017 Nov;37(8):975-981
pubmed: 28657384
Gynecol Oncol. 2018 Mar;148(3):622-631
pubmed: 29137809
Gynecol Oncol. 2018 May;149(2):310-317
pubmed: 29555332
Eur J Gynaecol Oncol. 1995;16(5):382-6
pubmed: 8549604

Auteurs

Marta Peri (M)

Medical Oncology Unit, Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio", Chieti, Italy.

Antonino Grassadonia (A)

Medical Oncology Unit, Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio", Chieti, Italy.

Laura Iezzi (L)

Medical Oncology Unit, Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio", Chieti, Italy.

Patrizia Vici (P)

Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

Michele De Tursi (M)

Medical Oncology Unit, Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio", Chieti, Italy.

Clara Natoli (C)

Medical Oncology Unit, Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio", Chieti, Italy.

Nicola Tinari (N)

Medical Oncology Unit, Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio", Chieti, Italy.

Marinella Zilli (M)

Medical Oncology Unit, SS Annunziata Hospital, Chieti, Italy.

Classifications MeSH